Name: Grace Therapeutics, Inc. (GRCE) Balance Sheet
Creator: FinSpry

Grace Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Grace Therapeutics, Inc. (GRCE) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Current Assets
Cash and Cash Equivalents	22.13	23.01	27.89	43.66	60.73	14.24	25.76
Short-Term Investments	0.00	0.00	0.02	13.32	9.79	0.00	0.00
Cash & Short-Term Investments	22.13	23.01	27.89	43.66	60.73	14.24	25.76
Accounts Receivable	0.13	0.37	0.80	0.55	0.53	0.55	1.19
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.45	0.36	0.60	0.35	0.77	2.58	0.05
Total Current Assets	22.71	24.01	29.29	45.28	62.37	18.46	27.97
Non-Current Assets
Property, Plant & Equipment (Net)	0.02	0.01	0.57	0.57	0.09	2.06	2.11
Goodwill	8.14	8.14	8.14	12.96	0.00	0.00	0.00
Intangible Assets	41.13	41.13	41.13	69.81	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.47	0.42
Total Non-Current Assets	49.28	49.29	49.83	83.34	0.09	6.30	8.93
Total Assets	71.99	73.30	79.12	128.62	62.46	24.76	36.90
Current Liabilities
Accounts Payable	0.60	1.68	3.34	3.16	1.49	7.32	12.31
Accrued Liabilities	1.33	0.18	2.09	1.48	1.38	0.00	0.00
Other Current Liabilities	1.33	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	1.93	1.68	3.41	3.26	1.58	7.40	13.67
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.41	0.19	0.00	0.07	0.00
Deferred Tax Liabilities	2.31	5.51	7.35	16.89	0.00	0.00	0.00
Other Non-Current Liabilities	1.14	4.36	0.00	0.01	5.22	0.00	0.00
Total Non-Current Liabilities	3.45	9.87	7.76	17.09	5.22	2.46	12.18
Total Liabilities	5.38	11.56	11.17	20.35	6.80	9.86	25.85
Stockholders' Equity
Common Stock	0.00	0.00	258.29	257.99	197.19	0.00	0.00
Retained Earnings	-220.69	-211.12	-198.27	-155.84	-146.02	-126.34	-100.83
Accumulated Other Comprehensive Income	-6.04	-6.04	-6.04	-6.04	-6.33	-7.89	-7.14
Additional Paid-in Capital	293.33	17.86	13.97	12.15	10.82	9.80	8.15
Shares Outstanding	13.72	9.40	7.44	7.38	0.00	0.00	0.00
Total Stockholders' Equity	66.61	61.74	67.96	108.27	55.66	12.99	11.05
Total Liabilities & Equity	71.99	73.30	79.12	128.62	62.46	24.76	36.90